Novo Nordisk Drops Out of Europe’s Top 10 Most Valuable Firms: What’s Behind the Shift?
Danish pharmaceutical giant Novo Nordisk has fallen out of Europe’s top ten most valuable companies, marking a significant shift in the region’s business landscape. The company’s market capitalization has declined…